This image is not available for purchase in your country.

Ponatinib cancer drug molecule

Ponatinib cancer drug molecule

F013/0648

Royalty Free

50.0 MB (372.7 KB compressed)

4539 x 3850 pixels

38.4 x 32.5 cm ⏐ 15.1 x 12.8 in (300dpi)

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

BUY PRINT Embed

Credit

MOLEKUUL / SCIENCE PHOTO LIBRARY MOLEKUUL / SCIENCE PHOTO LIBRARY

Caption

Ponatinib cancer drug molecule. Tyrosine kinase inhibitor used in treatment of chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL). Stylized skeletal formula (chemical structure). Atoms are shown as color-coded circles: hydrogen (hidden), carbon (grey), oxygen (red), nitrogen (blue), fluorine (cyan).

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}